Literature DB >> 2778709

Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.

M S Ching1, D J Morgan, R A Smallwood.   

Abstract

Various kinetic models have been developed to describe the elimination of substances by the liver, but there is no agreement about which model is the most appropriate, as experimental evaluation is incomplete and results conflict. We have shown previously that hepatic elimination of taurocholate is best described by models that embody a high degree of sinusoidal heterogeneity or mixing, whereas another study showed that elimination of diazepam is best described by models that embody a low degree of sinusoidal heterogeneity or mixing. To investigate this discrepancy we examined, in the isolated perfused rat liver, the simultaneous elimination of taurocholate and diazepam. The effect on hepatic availability of varying unbound fraction (fu) in a single pass, steady-state system was studied in six experiments for taurocholate (fu, 0.066-0.966) and diazepam (fu, 0.051-0.675) by varying perfusate albumin concentration (0-60 g l-1). As before, elimination of taurocholate was best described by models that embody a high degree of sinusoidal heterogeneity or mixing (i.e., venous equilibrium model, dispersion model with dispersion number = infinity). Diazepam elimination was best described by models that embody a low degree of sinusoidal heterogeneity or mixing (undistributed sinusoidal model, dispersion model with low dispersion number = 1.04). A third model, a distributed model incorporating heterogeneity of sinusoidal blood flows and intrinsic clearances, fitted the data for both taurocholate and diazepam. The fitted coefficients of variation of both flow and intrinsic clearance among the sinusoids were large for taurocholate (176 and 164, respectively), but for diazepam blood flow was large (200) whereas that for intrinsic clearance was small (0.807).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2778709

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination.

Authors:  C H Chou; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

2.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

3.  Application of the dispersion model for description of the outflow dilution profiles of noneliminated reference indicators in rat liver perfusion studies.

Authors:  A J Schwab; W Geng; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1998-04

4.  On the degree of solute mixing in liver models of drug elimination.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

5.  Are There Any Experimental Perfusion Data that Preferentially Support the Dispersion and Parallel-Tube Models over the Well-Stirred Model of Organ Elimination?

Authors:  Jasleen K Sodhi; Hong-Jaan Wang; Leslie Z Benet
Journal:  Drug Metab Dispos       Date:  2020-04-17       Impact factor: 3.922

6.  Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.

Authors:  J M Díaz-García; A M Evans; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1992-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.